Page 4 - Flipbook

LEARNING OBJECTIVES

By participating in this webinar, participants can expect to:

• Review of latest evidence for treatment of advanced urothelial

cancer

• Discuss the perspective on multidisciplinary approaches to optimize

first line SOC treatments of chemotherapy and immunotherapy

• Gain insight on new approaches/research to further advance

standard first-line treatment options for advanced urothelial

carcinoma